AFP and hepatocellular carcinoma: Higher AFP levels (1.015, 95% CI [1.005, 1.025], p = 0.003) and lower PLT levels (0.988, 95% CI [0.980, 0.995], p = 0.001) at baseline were associated with a higher probability to develop HCC in CHB group during the follow-up.